from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2066/cobI

LFCtreatmentdescriptionclass of inhibitor

0.246

Amikacinug/mL Amikacintranslation

-0.001

Cap5-10ug/mL Capreomycintranslation

0.117

Rox10-50 ug/mL Roxithromycintranslation

0.167

SM2-5 ug/mL Streptomycintranslation

-0.392

Tet5-10 ug/mL Tetracyclinetranslation

-2.223

Rif0.2-5ug/mL Rifampicintranscription

-0.978

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.208

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-2.882

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.258

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.474

Clofazimine10-13 ug/mL Clofaziminerespiration

0.480

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-2.038

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-1.765

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-1.658

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.631

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.138

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.648

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.775

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.637

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-1.132

KCN5-20 ug/mL Potassium cyaniderespiration

-0.957

NaN30.2-2 mM Sodium aziderespiration

-0.205

Nigericin50 uM Nigericinrespiration

-1.150

TRC10-150 ug/mL Triclosanrespiration

-1.929

TRZ10-25 ug/mL Thioridazinerespiration

-0.486

Valinomycin0.5-10 uM Valinomycinrespiration

0.935

ZnSO42 mM ZnSO4respiration

-0.990

menadione6-10 ug/mL Menadionerespiration

0.451

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.547

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.588

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.730

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.145

NRP_1Non-replicating persistence stage 1dosRassociated

0.518

Amp0.2mg/mL AmpicillincellWall

0.217

Cephalexin20-100 ug/mL CephalexincellWall

0.142

Cerulenin0.32-5 ug/mL CerulenincellWall

0.032

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.003

EMB10-20 ug/mL EthambutolcellWall

0.220

Eta12-40 ug/mL EthionamidecellWall

0.213

INH0.2-0.4 ug/mL IsoniazidcellWall

0.327

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.049

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.003

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.420

BZA0.12 mg/mL BenzamidearomaticAmides

0.033

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.539

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.462

H2O24 mM hydrogen peroxideDNAdamaging

0.450

Levo10 ug/mL LevofloxacinDNAdamaging

0.919

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.512

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.043

Oflox5-10 ug/mL OfloxacinDNAdamaging

1.296

UVUV-irradiationDNAdamaging

-1.206

ARP41-4 ug/mL Antitubercular compound ARP4?

0.999

Antimycin12.5-50 ug/mL Antimycin A?

0.359

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.404

PA_110-50 ug/mL Antitubercular compound PA-1?

0.288

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.731

PA8240.2-2 ug/mL PA-824?

-1.120

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.607

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.461

Verapamil50 uM Verapamil?

1.660

mercaptoethanol2 mM 2-Mercaptoethanol?

0.543

methoxatin10-20 ug/mL Methoxatin?